Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.58
+0.34 (5.54%)
At close: Feb 13, 2026, 4:00 PM EST
6.60
+0.02 (0.38%)
After-hours: Feb 13, 2026, 4:10 PM EST

Profound Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
237225202223234403
Market Cap Growth
50.01%11.58%-9.56%-4.57%-41.98%199.27%
Enterprise Value
217206176178163318
Last Close Price
6.607.518.4910.8911.2320.56
PS Ratio
16.5921.1028.0633.4334.0555.23
PB Ratio
7.383.736.474.302.904.14
P/TBV Ratio
7.413.756.574.353.064.35
EV/Sales Ratio
15.1519.2724.4326.5823.7743.61
Debt / Equity Ratio
0.150.090.250.160.020.02
Net Debt / Equity Ratio
-0.62-0.82-0.59-0.74-0.82-0.84
Net Debt / EBITDA Ratio
0.481.550.661.332.224.48
Net Debt / FCF Ratio
0.542.120.811.482.944.00
Asset Turnover
0.340.190.130.090.070.11
Inventory Turnover
0.530.570.390.480.620.85
Quick Ratio
3.329.445.2612.6316.5018.99
Current Ratio
4.1810.526.5814.8218.5620.33
Return on Equity (ROE)
-124.49%-60.70%-68.06%-43.23%-34.50%-38.71%
Return on Assets (ROA)
-62.44%-36.19%-33.05%-24.47%-19.79%-17.51%
Return on Capital Employed (ROCE)
-130.50%-51.90%-76.20%-49.10%-36.70%-18.90%
Earnings Yield
-16.59%-12.34%-14.02%-12.84%-13.12%-5.36%
FCF Yield
-15.82%-10.41%-11.19%-11.55%-9.57%-5.10%
Buyback Yield / Dilution
-22.70%-16.91%-1.69%-1.79%-18.33%-55.83%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q